Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-05

FDA Approved: PLASMA-LYTE A — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

FDA approved a supplemental application for Plasma-Lyte A, an intravenous electrolyte solution manufactured by Baxter Healthcare Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PLASMA-LYTE A (SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE)

Snippet

SUPPL AP for PLASMA-LYTE A (SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE)